All Articles
1 min read
Стартапы2026年9月23日
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Marina Temkin·TechCrunch — AI
Original SourceKey Takeaways
- 01.The round valued the AI biotech at $2 billion
- 02.It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
This material is provided as an extended analytical summary.
Read full article at sourceAggregated within AI Qazaqstan national intelligence stream with author attribution.
Related Intelligence
All stories →База знаний1 мин
新的全栈设计师
今天,Marvin Schwaibold 加入了我的行列,他是 Shopify 产品设计工作室的负责人。他将向我们展示他的幕后制作过程,>> [音乐] >> 我们将看到他如何使用最新的人工智能工具将他的设计变为现实,然后回顾一些观众提交的……
YouTube — Y Combinator AI
Kapital.kz
SMNTCN (Semanticon) — глобальные новости ИИ